Related Experiment Video
Updated: Jul 15, 2025
09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.7K
Interferon epsilon and ovarian cancer
Samar Elorbany1, Beatrice Malacrida1, Frances Balkwill1
1Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University of London, London, UK.
Trends in Cancer
|October 1, 2023
Summary
Interferon epsilon (IFNε) shows promise as a tumor suppressor in ovarian cancers. This finding expands the known roles of interferons beyond immunity and infection.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Interferons (IFNs) are crucial for immunity and antiviral responses.
- Common IFNs include IFNα, IFNβ, and IFNγ.
- The role of Interferon epsilon (IFNε) is less understood.
Purpose of the Study:
- To investigate the function of IFNε in cancer.
- To explore the potential of IFNε as a therapeutic agent.
Main Methods:
- Analysis of gene expression data in serous ovarian cancers.
- In vitro experiments to assess IFNε's effect on cancer cells.
Main Results:
- IFNε expression is reduced in serous ovarian cancers.
- IFNε demonstrates tumor-suppressive activity in preclinical models.
- IFNε inhibits cancer cell proliferation and promotes apoptosis.
Conclusions:
- IFNε acts as a tumor suppressor in serous ovarian cancer.
- Targeting IFNε could be a novel therapeutic strategy for ovarian cancer.
